Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Howard

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Pediatric Blood & Cancer|November 25, 2014
SIOP PODC adapted treatment recommendations for standard-risk medulloblastoma in low and middle income settingsJeannette Parkes, Marc Hendricks, Peter Ssenyonga, et al.
Pediatric Blood & Cancer|April 5, 2005
AMOR: a proposed cooperative effort to improve outcomes of childhood cancer in Central AmericaFederico Antillon, Fulgencio L Baez, Ronald Barr, et al.
Physical Therapy|January 19, 2008
Relationships among severity of osteonecrosis, pain, range of motion, and functional mobility in children, adolescents, and young adults with acute lymphoblastic leukemiaVictoria G Marchese, Barbara H Connolly, Colleen Able, et al.
ACS Sensors|December 2, 2021
Gravity-Driven Microfluidic Siphons: Fluidic Characterization and Application to Quantitative ImmunoassaysNuno M Reis, Sarah H Needs, Sophie M Jegouic, et al.
Revista Brasileira De Hematologia E Hemoterapia|October 11, 2012
Hematology in Latin America: where are we? Analysis of the reports of Societies of Hematology associated organization of the Highlights of ASH in Latin AmericaRaul Gabús, Sebastian Galeano, Carmino Antonio de Souza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2004
Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's diseaseMelissa M Hudson, Matthew Krasin, Michael P Link, et al.
British Journal of Haematology|January 14, 2026
Prognostic role of PET/CT volumetric parameters in paediatric Hodgkin lymphoma: A systematic review and expert recommendations from the International SEARCH for CAYAHL GroupS Claire Gowdy, Jamie E Flerlage, Jennifer Seelisch, et al.
Blood|January 13, 2026
Dose-dense chemotherapy enables elimination of RT for majority of low-risk pediatric Hodgkin lymphoma: PHC study HOD08Jamie E Flerlage, Angela M Feraco, Yiwang Zhou, et al.
JCO Global Oncology|December 23, 2025
Latin American Consensus on the Use of Anti-GD2 Monoclonal Antibody Therapy in Patients With High-Risk NeuroblastomaGabriela I Villanueva, Sandra Alarcón, Diana Bonilla, et al.
Clinical Pharmacology and Therapeutics|April 17, 2013
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementationA R Shuldiner, M V Relling, J F Peterson, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Pediatric Blood & Cancer|November 25, 2014
SIOP PODC adapted treatment recommendations for standard-risk medulloblastoma in low and middle income settingsJeannette Parkes, Marc Hendricks, Peter Ssenyonga, et al.
Pediatric Blood & Cancer|April 5, 2005
AMOR: a proposed cooperative effort to improve outcomes of childhood cancer in Central AmericaFederico Antillon, Fulgencio L Baez, Ronald Barr, et al.
Physical Therapy|January 19, 2008
Relationships among severity of osteonecrosis, pain, range of motion, and functional mobility in children, adolescents, and young adults with acute lymphoblastic leukemiaVictoria G Marchese, Barbara H Connolly, Colleen Able, et al.
ACS Sensors|December 2, 2021
Gravity-Driven Microfluidic Siphons: Fluidic Characterization and Application to Quantitative ImmunoassaysNuno M Reis, Sarah H Needs, Sophie M Jegouic, et al.
Revista Brasileira De Hematologia E Hemoterapia|October 11, 2012
Hematology in Latin America: where are we? Analysis of the reports of Societies of Hematology associated organization of the Highlights of ASH in Latin AmericaRaul Gabús, Sebastian Galeano, Carmino Antonio de Souza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2004
Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's diseaseMelissa M Hudson, Matthew Krasin, Michael P Link, et al.
British Journal of Haematology|January 14, 2026
Prognostic role of PET/CT volumetric parameters in paediatric Hodgkin lymphoma: A systematic review and expert recommendations from the International SEARCH for CAYAHL GroupS Claire Gowdy, Jamie E Flerlage, Jennifer Seelisch, et al.
Blood|January 13, 2026
Dose-dense chemotherapy enables elimination of RT for majority of low-risk pediatric Hodgkin lymphoma: PHC study HOD08Jamie E Flerlage, Angela M Feraco, Yiwang Zhou, et al.
JCO Global Oncology|December 23, 2025
Latin American Consensus on the Use of Anti-GD2 Monoclonal Antibody Therapy in Patients With High-Risk NeuroblastomaGabriela I Villanueva, Sandra Alarcón, Diana Bonilla, et al.
Clinical Pharmacology and Therapeutics|April 17, 2013
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementationA R Shuldiner, M V Relling, J F Peterson, et al.
Pageof 7